Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | O. Pellerito et al., Mol. Pharmacol., May 2010; 77: 854 - 863 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | F. Damiano et al., Biochem. J., 2013, 449: 543–553, doi:10.1042/BJ20120906 | ||
hESC-RPE |
Human embryonic stem cell-derived retinal pigment epithelium cells | Human | sensory organs | primary cell | siRNA | RNA-Interference | Metafectene PRO | publication | E. Ramsay et al., Pharmaceutics, 2020, 12(7): 667, doi: 10.3390/pharmaceutics12070667 | Link | |||
HK-2 |
Human kidney cell line HPV-16 transformed | ATCC CRL-2190 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Alcaraz, Dissertation, 2015, University of Barcelona | ||
HL-60 |
Human adult acute myeloid leukemia cell line | ATCC CCL-240 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | B. Landry et al., PLoS ONE, 2012, 7(8): e44197, doi:10.1371/journal.pone.0044197 | Link | |
HLF |
Human lung fibroblasts | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | X. Deng et al., J. Cell. Biochem., 2017, 118: 4012-4019, DOI 10.1002/jcb.26057 | |||
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | N. M. Trinchant, PhD Thesis, 2013, Universitat de Barcelona | Link | |
HT-29 |
Human colorectal adenocarcinoma cell line | ATCC HTB-38 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | O. Pellerito et al., Apoptosis, 2014, 19: 1029-1042, DOI 10.1007/s10495-014-0985-0 | ||
HTC |
Rat hepotoma cell line | Rat | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ullio et al., Autophagy, 2015, 11(12): 2184-2198, DOI: 10.1080/15548627.2015.1106662 | Link | ||
HTC |
Rat hepotoma cell line | Rat | digestive organs | cell line | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ullio et al., J. Lipid Res., Jun 2012; 53: 1134 - 1143 | Link | |||
hTM |
Human trabecular meshwork cells | Human | sensory organs | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Y. Su et al., Molecular Vision, 2012, 18: 1881-1884, | Link | ||
HuH7 |
Human hepatocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ullio et al., J. Lipid Res., Jun 2012; 53: 1134 - 1143 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050-2057, doi.org/10.1016/j.bbrc.2017.08.023 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H.-Y. Lee et al., Korean Circ. J., 2012, 42: 239-245, doi.org/10.4070/kcj.2012.42.4.239 | Link | |
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | H.-Y. Lee et al., Cardiovasc Res, Jan 2013; 97: 143 - 152 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050e2057 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link | |
IGR-37 |
Human cutaneous melanoma cell line | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Venza et al., Int. Immunopharmacol., 2014, 21: 439–446; doi.org/10.1016/j.intimp.2014.05.024 | |||
INS-1E |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Cadavez Trigo, PhD Thesis, 2014, Seoul National University | Link | ||
INS-1E |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. A. Rebuffat et al., Diabetologia, 2013, 56: 2446–2455, DOI 10.1007/s00125-013-3030-x | Link | ||
INS-1E |
Rat pancreatic tumor (insulinoma) derived ß cell line | Rat | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Cadavez et al., PLoS ONE, 2014, 9(7): e101797, doi:10.1371/journal.pone.0101797 | Link | ||
KG1 |
Human myelogenous leukemia cell line | ATCC CRL-8031 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | B. Landry et al., PLoS ONE, 2012, 7(8): e44197, doi:10.1371/journal.pone.0044197 | Link | |
LAN1 |
Human neuroblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | A. Groß et al., Cancer Res., 2018, DOI: 10.1158/0008-5472.CAN-17-1860 | |||
LBL |
Human lymphoblastoid cells | Human | immune system | unknown | siRNA | RNA-Interference | Metafectene PRO | publication | C. Kerzendorfer et al., Hum. Mol. Genet., Apr 2010; 19: 1324 - 1334 | Link | |||
LCL |
Human lymphoblastoid cell line | Human | immune system | cell line | siRNA | RNA-Interference | Metafectene PRO | publication | C. Kerzendorfer et al., Hum. Mol. Genet., May 2012; 21: 2181 - 2193 | Link |